Association of A1AT With Poor Functional Outcome in Patients With Acute Ischemic Stroke
Based on our data, we cannot claim that A1AT is an independent biomarker of ischemic stroke. Nevertheless, A1AT is potentially involved in stroke outcomes and might be explored as a potential therapeutic target.
Authors
- Noelia Díaz‐Troyano (ORCID: https://orcid.org/0000-0002-9392-0142)
- Paula García‐Rodríguez (ORCID: https://orcid.org/0000-0001-6596-8002)
- Marcel Lamana‐Vallverdú (ORCID: https://orcid.org/0009-0000-2874-6523)
- Joan Montaner (ORCID: https://orcid.org/0000-0003-4845-2279)
- Alba Simats (ORCID: https://orcid.org/0000-0002-0415-1135)
- Júlia Faura (ORCID: https://orcid.org/0000-0002-8436-1377)
- Laura Ramiro (ORCID: https://orcid.org/0000-0002-4121-4609)
- Alejandro Bustamante (ORCID: https://orcid.org/0000-0003-4390-8900)
- Daisy Guamán-Pilco (ORCID: https://orcid.org/0000-0002-9212-0872)
- Anna Peñalba (ORCID: https://orcid.org/0000-0002-0241-2602)
Institutions
- Hebron University (PS)
- Universitat Autònoma de Barcelona (ES)
- Consejo Superior de Investigaciones Científicas (ES)
- Hospital Universitario Virgen Macarena (ES)
Publication Details
- Journal
- Journal of the American Heart Association
- Published
- 2025-04-18
- DOI
- https://doi.org/10.1161/jaha.124.036727
- Citations
- 1
- Primary Topic
- Protease and Inhibitor Mechanisms
- Type
- article
- Field-Weighted Citation Impact
- 0.94